1. Home
  2. CPIX vs RAND Comparison

CPIX vs RAND Comparison

Compare CPIX & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • RAND
  • Stock Information
  • Founded
  • CPIX 1999
  • RAND 1969
  • Country
  • CPIX United States
  • RAND United States
  • Employees
  • CPIX N/A
  • RAND N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • RAND Finance: Consumer Services
  • Sector
  • CPIX Health Care
  • RAND Finance
  • Exchange
  • CPIX Nasdaq
  • RAND Nasdaq
  • Market Cap
  • CPIX 46.2M
  • RAND 44.7M
  • IPO Year
  • CPIX 2009
  • RAND N/A
  • Fundamental
  • Price
  • CPIX $3.64
  • RAND $14.74
  • Analyst Decision
  • CPIX
  • RAND
  • Analyst Count
  • CPIX 0
  • RAND 0
  • Target Price
  • CPIX N/A
  • RAND N/A
  • AVG Volume (30 Days)
  • CPIX 24.8K
  • RAND 4.0K
  • Earning Date
  • CPIX 11-06-2025
  • RAND 11-05-2025
  • Dividend Yield
  • CPIX N/A
  • RAND 11.24%
  • EPS Growth
  • CPIX N/A
  • RAND N/A
  • EPS
  • CPIX N/A
  • RAND N/A
  • Revenue
  • CPIX $42,071,813.00
  • RAND $7,966,118.00
  • Revenue This Year
  • CPIX N/A
  • RAND N/A
  • Revenue Next Year
  • CPIX N/A
  • RAND N/A
  • P/E Ratio
  • CPIX N/A
  • RAND N/A
  • Revenue Growth
  • CPIX 11.34
  • RAND 1.16
  • 52 Week Low
  • CPIX $1.04
  • RAND $13.82
  • 52 Week High
  • CPIX $7.25
  • RAND $31.89
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 54.53
  • RAND 47.90
  • Support Level
  • CPIX $3.08
  • RAND $14.27
  • Resistance Level
  • CPIX $3.61
  • RAND $15.07
  • Average True Range (ATR)
  • CPIX 0.21
  • RAND 0.40
  • MACD
  • CPIX 0.04
  • RAND 0.04
  • Stochastic Oscillator
  • CPIX 73.80
  • RAND 58.64

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: